| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T52 |
0-101 |
Sentence |
denotes |
Virus Baltimore classification Kinase inhibitors showing antiviral activity(potential kinase targets) |
| T53 |
102-172 |
Sentence |
denotes |
SARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib |
| T54 |
173-262 |
Sentence |
denotes |
(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full) |
| T55 |
263-301 |
Sentence |
denotes |
abemaciclib, gilteritinib, osimertinib |
| T56 |
302-325 |
Sentence |
denotes |
(unpublished; preprint: |
| T57 |
326-395 |
Sentence |
denotes |
https://www.biorxiv.org/content/10.1101/2020.03.20.999730v3.full.pdf) |
| T58 |
396-493 |
Sentence |
denotes |
SARS-CoV Group IV, positive sense single-stranded RNA virus imatinib, dasatinib, nilotinib (ABL2) |
| T59 |
494-503 |
Sentence |
denotes |
(27) (29) |
| T60 |
504-595 |
Sentence |
denotes |
MERS-CoV Group IV, positive sense single-stranded RNA virus imatinib, dasatinib (ABL2) (27) |
| T61 |
596-623 |
Sentence |
denotes |
saracatinib (LYN, FYN) (33) |
| T62 |
624-644 |
Sentence |
denotes |
sorafenib (RAF) (68) |
| T63 |
645-751 |
Sentence |
denotes |
Dengue Group IV, positive sense single-stranded RNA virus dasatinib, saracatinib (SRC, FYN) (34) (35) (36) |
| T64 |
752-804 |
Sentence |
denotes |
sunitinib, erlotinib (AAK1, GAK, AXL, KIT, RET) (46) |
| T65 |
805-910 |
Sentence |
denotes |
Hepatitis C Group IV, positive sense single-stranded RNA virus sunitinib, erlotinib (AAK1, GAK) (41) (42) |
| T66 |
911-954 |
Sentence |
denotes |
gefitinib, erlotinib (EGFR) (59) ((56) (57) |
| T67 |
955-1041 |
Sentence |
denotes |
West Nile Group IV, positive sense single-stranded RNA virus sunitinib, erlotinib (46) |
| T68 |
1042-1123 |
Sentence |
denotes |
Zika Group IV, positive sense single-stranded RNA virus sunitinib, erlotinib (46) |
| T69 |
1124-1201 |
Sentence |
denotes |
Ebola Group V, negative sense single-stranded RNA virus nilotinib (ABL1) (24) |
| T70 |
1202-1280 |
Sentence |
denotes |
Influenza A Group V, negative sense single-stranded RNA virus alvocidib (CDK9) |
| T71 |
1281-1380 |
Sentence |
denotes |
Human cytomegalovirus Group 1, double-stranded DNA virus gefitinib, erlotinib (EGFR) (59) (57) (56) |
| T72 |
1381-1444 |
Sentence |
denotes |
Vaccinia Group 1, double-stranded DNA virus imatinib (ABL) (25) |
| T73 |
1445-1525 |
Sentence |
denotes |
Herpes simplex type 1 Group 1, double-stranded DNA virus palbociclib (CDK6) (62) |
